SCHEMBL23328892

SCHEMBL23328892

CCCCNC(=S)NCCS(=O)(=O)OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.41
HTT P42858 4/20 0.41
MEN1 O00255 3/20 0.41
ALDH1A1 P00352 4/20 0.40
MAPT P10636 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
LMNA P02545 2/20 0.39
GAA P10253 3/20 0.38
ACHE P22303 1/20 0.38
EPHX1 P07099 1/20 0.38
MMP2 P08253 1/20 0.38
EPHX2 P34913 1/20 0.38
PABPC1 P11940 1/20 0.38
ALOX12 P18054 2/20 0.37
CA12 O43570 1/20 0.37
CA14 Q9ULX7 1/20 0.37
NPSR1 Q6W5P4 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23329079 0.95 MEN1 (0.42) KMT2AHTTMEN1ALDH1A1MAPT
SCHEMBL23328389 0.84 EPHX1 (0.55) KMT2AHTTMEN1ALDH1A1LMNA
SCHEMBL23328734 0.81 EPHX1 (0.55) KMT2AHTTMEN1ALDH1A1LMNA
SCHEMBL23328891 0.80 ALDH1A1 (0.46) KMT2AHTTMEN1ALDH1A1MAPT
SCHEMBL23329077 0.78 EPHX2 (0.50) KMT2AHTTMEN1ALDH1A1MAPT
SCHEMBL17219 0.77 KMT2A (0.57) KMT2AHTTMEN1ALDH1A1MAPT
SCHEMBL23328424 0.74 KMT2A (0.46) KMT2AHTTMEN1ALDH1A1MAPT
SCHEMBL5533796 0.73 FAAH (0.56) KMT2AMEN1ALDH1A1MAPTALOX12
SCHEMBL2909419 0.73 FAAH (0.56) KMT2AMEN1ALDH1A1MAPTALOX12
SCHEMBL8444285 0.73 FAAH (0.56) KMT2AMEN1ALDH1A1MAPTALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11701333-B2 Antibacterial compounds Kent Innovation & Enterprise (GB) 2023-07-18 US disclosed
US-20210128501-A1 ANTIBACTERIAL COMPOUNDS KENT INNOVATION & ENTERPRISE, UNIVERSITY OF KENT (GB) 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11701333-B2 Antibacterial compounds ARF1, ARL1, TLR1 KMT2A 2533/4885HTT 2350/4885MEN1 1300/4885
US-20210128501-A1 ANTIBACTERIAL COMPOUNDS ARF1, ARL1, TLR1 KMT2A 2533/4885HTT 2350/4885MEN1 1300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.